ReleaseWire

Global Market Direct's pharmaceuticals report, "ImmunoGen, Inc. - Product Pipeline Review - 2014" provides data on the ImmunoGen, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Orlando, Florida – There are hundreds of weight loss supplements out there, and that may have made choosing the right one a bit challenging for consumers. This is especially that substandard products have proliferated in the health and fitness market. One supplement that is believed to be an efficient weight loss aid is raspberry ketone liquid supplement . And, for consumers to be assured of its quality and safety, they should choose the one that is made in the USA and that carries the GMP seal.

Global Market Direct's pharmaceuticals report, "Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014" provides data on the Avanir Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Spinal Muscular Atrophy (SMA) , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinal Muscular Atrophy (SMA) . Spinal Muscular Atrophy (SMA) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Starpharma Holdings Limited - Product Pipeline Review - 2014" provides data on the Starpharma Holdings Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

In every aspect of life, modern society is throwing up more challenges than ever, and people are finding them harder to cope with despite the fact that we supposedly have never had it so good. This is likely because life used to involve a mix of physical and mental challenges, but now almost every challenge or problem we face is entirely mental. As a result, people find themselves mentally fatigued or unable to learn fast enough to adapt to this quickly changing world. Peak Nootropics offer an exciting solution that is catching on like wildfire in 2014, with brain enhancing supplements that give students and executives the edge.

Global Market Direct's pharmaceuticals report, "MedImmune, LLC - Product Pipeline Review - 2014" provides data on the MedImmune, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Oramed Pharmaceuticals, Inc. - Product Pipeline Review - 2014" provides data on the Oramed Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The pressure to look good has become a priority with the advent of global urbanization. With a standard lifestyle, it is only fair that a person should put some energy and money into looking good. Today, the average single adult spends half their earning on buying cloths, cosmetics, and other fitness products and routines.

Global Market Direct's pharmaceuticals report, "Immunomedics, Inc. - Product Pipeline Review - 2014" provides data on the Immunomedics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Genentech, Inc. - Product Pipeline Review - 2014" provides data on the Genentech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The offered range includes creams to erase the signs of aging caused by suns and the environment along with serums for restoring the vitality and density of mature skin with their nutrients. All the offered products are result of ground breaking researches and have the approval of many users as far as their benefits are concerned.

Global Market Direct's pharmaceuticals report, "OXiGENE, Inc. - Product Pipeline Review - 2014" provides data on the OXiGENE, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Almac Discovery Ltd. - Product Pipeline Review - 2014" provides data on the Almac Discovery Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Allergy Therapeutics plc - Product Pipeline Review - 2014" provides data on the Allergy Therapeutics plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Generex Biotechnology Corporation - Product Pipeline Review - 2014" provides data on the Generex Biotechnology Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "CSL Limited - Product Pipeline Review - 2014" provides data on the CSL Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014" provides data on the Ampio Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Antisense Therapeutics Limited - Product Pipeline Review - 2014" provides data on the Antisense Therapeutics Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA). Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Destiny Pharma Ltd. - Product Pipeline Review - 2014" provides data on the Destiny Pharma Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Peptides are amino acid chains that are artificially produced in the laboratory and act as triggers to promote chemical reactions and hormone production. They have been used in mass spectrometry, studying protein structure and even in developing treatments for cancer. Such vital chemical compounds are of course pricey, and researchers are always struggling to make their funding stretch to reach their ambitions. That process just got a little easier however, as Genco Pepide, one of the United States’ leading peptide producers, announced a 20% off tax sale until April 17th.

GlobalData's clinical trial report, "Varicose Ulcers Global Clinical Trials Review, H1, 2014" provides data on the Varicose Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Varicose Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Varicose Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The Corporate Whistleblower Center says,"Because long term care facilities are not highly regulated, it is not uncommon for these types of facilities to overcharge Medicare by hundreds of thousands or even millions of dollars each year. This presents an excellent opportunity for employees, or insiders to document their proof of fraud and do the right thing by stepping forward. Because the government relies on whistleblowers so heavily, they have the potential to be rewarded handsomely for their information. It’s not uncommon for whistleblowers to get hundreds of thousands of dollars in reward money.” For more information healthcare whistleblowers can contact the Corporate Whistleblower Center anytime at 866-714-6466.

CEL-SCI Corporation reported accelerating progress in patient enrollment in the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection). Approximately 146 patients have been enrolled in the Phase III study to date.